scout
|Videos|May 2, 2022

Venetoclax in Combination with Carfilzomib for Multiple Myeloma Treatment

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. Oncologists discuss the use of carfilzomib for multiple myeloma and their typical treatment regimens of choice.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME